“SGRT provides the potential to reduce treatment-related errors which could affect patient outcomes, especially within the realm of hypo-fractionated treatments.”
– Juergen Meyer, University of Washington Medical Center and Department of Radiation Oncology, Seattle Cancer Care Alliance, Seattle, WA, USA, and senior author for the study.
C-RAD offers a full range of SGRT solutions, along with robust training, implementation and vendor integration to help ensure the best possible treatment outcome while maximizing efficiency for the treatment team.
You might also be interested in

I was recently honored to be interviewed by two major publications in Colombia—La Nota Económica and La Patria—to discuss how Surface Guided Radiation Therapy (SGRT) is transforming cancer treatment in…

Daniel Speir, Chief Radiation Therapist, Willis-Knighton Health System, Shreveport, La. A newly published article by Jennifer Cook, C-RAD Clinical Applications Specialist at Vertec Scientific, a distributor of C-RAD products in…
Contact us
Contact your local office
We have service support groups the USA, China, Germany, France & Sweden